Introduction: Limitation of pharmaceutical application of resveratrol (RSV) and piceatannol (PIC) continue to exist, there is a need to obtain the superior analogs of two stilbenes with promoted activity, stability, and bioavailability. Microbial transformation has been suggested as a common and efficient strategy to solve the above problems.
Methods: In this study, was selected to transform RSV and PIC. LC-MS and NMR spectroscopies were used to analyze the transformed products and identify their structures. The biological activities of these metabolites were evaluated with GPR119 agonist and insulin secretion assays. Single factor tests were employed to optimize the biotransformation condition.
Results: Three new methylglucosylated derivatives of PIC (-) and two known RSV methylglucosides ( and ) were isolated and characterized from the fermentation broth. Among them, not only showed moderate GPR119 agonistic activity with 65.9%, but also promoted insulin secretion level significantly (12.94 ng/mg protein/hour) at 1 μM. After optimization of fermentation conditions, the yield of reached 45.53%, which was increased by 4.2-fold compared with the control.
Discussion: Our work presents that 3--MG PIC (), obtained by microbial transformation, is an effective and safer ligand targeting GPR119, which lays a foundation for the anti-diabetic drug design in the future.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081513 | PMC |
| http://dx.doi.org/10.3389/fmicb.2023.1148513 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chronic metabolic effects of novel gut-oriented small-molecule GPR119 agonists in diet-induced obese mice.
Biomed Pharmacother
December 2024
Department of Medicine and Surgery, University of Parma, Parma 43125, Italy. Electronic address:
Article Synopsis
- * Over 10 weeks, the treatments led to significant improvements in blood glucose levels and weight management, with the combination therapy restoring important metabolic hormones and enhancing liver health.
- * The findings suggest that these new GPR119 agonists, especially when used with DPP-IV inhibitors, could be promising for treating metabolic dysfunctions and liver issues associated with type-2 diabetes, indicating a need for further research.
What is holding back preclinical GPR119 agonists from their potential as the therapeutics of type 2 diabetes?
Expert Opin Ther Targets
October 2024
Institute of Liver diseases, Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Enteroendocrine cell-derived peptide YY signalling is stimulated by pinolenic acid or Intralipid and involves coactivation of fatty acid receptors FFA1, FFA4 and GPR119.
Neuropeptides
December 2024
King's College London, Wolfson Sensory, Pain and Regeneration Centre, Hodgkin Building, Guy's Campus, London SE1 1UL, UK. Electronic address:
Long chain fatty acids are sensed by enteroendocrine L cells that express free-fatty acid receptors, including FFA1, FFA4 and the acylethanolamine receptor GPR119. Here we investigated the acute effects of single or multiple agonism at these G protein-coupled receptors in intestinal mucosae where L cell-derived peptide YY (PYY) is anti-secretory and acts via epithelial Y receptors. Mouse ileal or colonic mucosae were mounted in Ussing chambers, voltage-clamped and the resultant short-circuit current (I) recorded continuously.
View Article and Find Full Text PDFTerazosin, a repurposed GPR119 agonist, ameliorates mitophagy and β-cell function in NAFPD by inhibiting MST1-Foxo3a signalling pathway.
Cell Prolif
October 2024
School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia, China.
Article Synopsis
- * The study investigates terazosin, a drug identified through screening, to see how it improves β-cell function by activating the MST1-Foxo3a pathway and promoting mitophagy.
- * Results show terazosin enhances insulin secretion and overall pancreatic health in NAFPD mice by restoring mitochondrial function and inhibiting a harmful signaling pathway, making it a potential treatment for patients with NAFPD and hypertension.
N-acyl glycines produced by commensal bacteria potentiate GLP-1 secretion as GPCR ligands.
Biomed Pharmacother
November 2024
Institute of Molecular and Industrial Biotechnology, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Stefanowskiego Street 2/22, Lodz 90-537, Poland.
Commensal microbiota is crucial for nutrient digestion and production of biologically active molecules, many of which mimic endogenous ligands of human GPCRs. Bacteroides spp. are among the most abundant bacteria residing in the human gut and their absence has been positively correlated with metabolic disorders.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!